Evidence map›Paper›PMID 38190737›Full record

ArticleTranslational behavioral medicine2024

Evaluation of mailed results versus telephone disclosure of normal cancer genetic test results in a low-risk underserved population.

Marian J Gilmore, Michael C Leo, Laura M Amendola, Katrina A B Goddard, Jessica Ezzell Hunter, Galen Joseph, Tia L Kauffman, Bradley Rolf, Elizabeth Shuster, Jamilyn M Zepp and 2 more

Open access · greenAbstract read
In one paragraph

Article in Translational behavioral medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 1 country.

Marian J GilmoreDepartment of Translational and Applied Genomics, Kaiser Permanente Center for Health Research, Portland, OR, USA.
Michael C LeoKaiser Permanente Center for Health Research, Portland, OR, USA.
Laura M AmendolaMedical Genomics Research, Illumina Inc., San Diego, CA, USA.
Katrina A B GoddardDepartment of Translational and Applied Genomics, Kaiser Permanente Center for Health Research, Portland, OR, USA.
Jessica Ezzell HunterDepartment of Translational and Applied Genomics, Kaiser Permanente Center for Health Research, Portland, OR, USA.
Galen JosephDepartment of Humanities and Social Sciences, University of California, San Francisco School of Medicine, San Francisco, CA, USA.
Tia L KauffmanKaiser Permanente Center for Health Research, Portland, OR, USA.
Bradley RolfDivision of Medical Genetics, Department of Medicine, University of Washington, Seattle, WA, USA.
Elizabeth ShusterKaiser Permanente Center for Health Research, Portland, OR, USA.
Jamilyn M ZeppDepartment of Translational and Applied Genomics, Kaiser Permanente Center for Health Research, Portland, OR, USA.
Benjamin S WilfondTreuman Katz Center for Pediatric Bioethics, Seattle Children's Research Institute, Seattle, WA, USA.
Barbara B BieseckerAnalytics, RTI International, Washington, DC, USA.
Kaiser Permanente Center for Health Research · USIllumina (United States) · USRTI International · USSeattle Children's Hospital · USUniversity of California, San Francisco · USUniversity of Washington Medical Center · US

Funding

Exome sequencing in Diverse Populations in Colorado & OregonU01HG007292 · NHGRI · KAISER FOUNDATION RESEARCH INSTITUTE · PI LEO, MICHAEL C, WILFOND, BENJAMIN SIMON · 2017 to 2021
$15.7M
Evolving Our Partnership: The CSER2 Centralized Support Coordinating CenterU24HG007307 · NHGRI · UNIVERSITY OF WASHINGTON · PI FULLERTON, STEPHANIE MALIA, JARVIK, GAIL PAIRITZ · 2017 to 2021
$5.8M
Coordinating CenterNHGRI NIH HHS U01 HG007292NHGRI NIH HHS U01HG007292NHGRI NIH HHS U24 HG007307
6 · The paper itself

Abstract

Scalable models for result disclosure are needed to ensure large-scale access to genomics services. Research evaluating alternatives to genetic counseling suggests effectiveness; however, it is unknown whether these findings are generalizable across populations. We assessed whether a letter is non-inferior to telephone genetic counseling to inform participants with no personal or family history of cancer of their normal results. Data were collected via self-report surveys before and after result disclosure (at 1 and 6 months) in a study sample enriched for individuals from underserved populations. Primary outcomes were subjective understanding of results (global and aggregated) and test-related feelings, ascertained via three subscales (uncertainty, negative emotions, and positive feelings) of the Feelings About genomiC Testing Results (FACToR) measure. Secondary outcomes related to satisfaction with communication. Non-inferiority tests compared outcomes among disclosure methods. Communication by letter was inferior in terms of global subjective understanding of results (at 1 month) and non-inferior to telephoned results (at 6 months). Letter was non-inferior to telephone for aggregated understanding (at 6 months). Letter was superior (at 1 month) to telephone on the uncertainty FACToR subscale. Letter was non-inferior to telephone on the positive-feelings FACToR subscale (at 6 months). Letter was non-inferior to telephone for satisfaction with mode of result delivery and genetic test results. Communication via letter was inferior to telephone in communicating the "right amount of information." The use of written communication to relay normal results to low-risk individuals is a promising strategy that may improve the efficiency of care delivery.

Indexed as

Genetic CounselingGenetic TestingNeoplasmsTelephoneAdultAgedDisclosureFemaleHumansMaleMiddle AgedPostal ServiceVulnerable Populationsalternative result delivery modelgenetic counselingnormal test resultspatient satisfactionpatient understandingtest-related feelings

Identifiers

PMID38190737
PMCPMC11208290
OpenAlexW4390658573

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.